Resources

Glossary

Cost Benefit Analysis: A form of comparative economic analysis that evaluates two or more policy alternatives in terms of their relative costs and outcomes, where both the costs and outcomes are expressed in monetary terms (2).

Cost Effectiveness Analysis: A form of comparative economic analysis that evaluates two or more policy alternatives in terms of their relative costs and outcomes, where the outcomes are measured in a single natural unit (e.g. life-years gained, disease case averted etc) (2).

Cost Minimization Analysis: A form of comparative economic analysis that compares the costs of two or more policy alternatives which are all assumed to have equivalent health effects (2).  

Cost Utility Analysis: A form of comparative economic analysis that evaluates two or more policy alternatives in terms of their relative costs and outcomes, where the outcomes are expressed by a generic measure of health status that considers both the effect on mortality and morbidity (e.g., quality-adjusted life-years (QALYs) (2).

Delphi Survey: A structured technique to gather expert opinions on a specific topic through multiple rounds of anonymous questionnaires, aiming to achieve a consensus or convergence of views. An eDelphi uses software designed for the qualitative processes of the Delphi method (7).

Economic Evaluations: A specific type of health economic analysis that explicitly compare the costs (use of resources) and consequences (effects) of the health intervention(s) in question to an alternative course of action, known as the comparator (2).

Health Economics: a field that focuses on how we use healthcare resources and how healthcare policies affect people, healthcare providers, and society. The main objective is to ensure that healthcare resources are used efficiently and that everyone has equal access to quality healthcare services. Health economists use advanced analytical techniques, like math and statistics, to make recommendations to policymakers in Canada. By providing evidence-based policy suggestions, health economists work to improve the health outcomes of Canadians and ensure that everyone can access high-quality healthcare services.

Health Technology Assessment: A multidisciplinary process that uses explicit methods to determine the value of a health technology at different points in its lifecycle. The purpose is to inform decision-making in order to promote an equitable, efficient, and high-quality health system (1).

Patient Engagement: Meaningful and active collaboration between researchers and patient partners in governance, priority setting, conducting research, and knowledge translation. Depending on the context, patient-oriented research may also engage people who bring the collective voice of specific, affected communities (3).

Patient Partner: An overarching term inclusive of anyone with lived experience of a health condition, including patients, caregivers, and family members, who are actively involved in research beyond simply being a research participant. This engagement can involve various roles, like participating on governing boards, co-developing research methodology, or contributing to knowledge translation (4).

Scoping Review: A type of literature review that aims to systematically map the breadth of evidence on a specific topic, identifying key concepts, research gaps, and the types of evidence available (5).  

Umbrella Review: A systematic collection and assessment of multiple systematic reviews and meta-analyses on a specific research topic (6).

References

​1.    international H-HTA. What is HTA?  Intro to HTA   HTAi; 2025 [Available from: https://htai.org/what-is-hta/].

​2.    Turner HC, Archer RA, Downey LE, Isaranuwatchai W, Chalkidou K, Jit M, Teerawattananon Y. An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations. Frontiers in Public Health. 2021;9.

​3.    First SfPOR-S-PP. Patient Engagement Framework. 2014.

4.    Alliance SE. Patient and Public Partner Financial Compensation Policy and Protocol. Toronto, ON; 2025.

​5.    Pollock D, Evans C, Menghao Jia R, Alexander L, Pieper D, Brandão de Moraes É, et al. “How-to”: scoping review? Journal of Clinical Epidemiology. 2024;176:111572.

​6.    Belbasis L, Bellou V, Ioannidis JPA. Conducting umbrella reviews. BMJ Medicine. 2022;1(1):e000071.

​7.    Software Eo-DM. eDelphi 2025 2025 [Available from: https://www.edelphi.org/].